UONDDL
IMMU

University of Notre Dame du Lac’s Immunomedics Inc IMMU Stock Holding History

University of Notre Dame du Lac’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-124,472
Closed -$1.78M – 72
2018
Q4 		$1.78M Buy
124,472
+785
+0.6% +$15.6K 0.43% 66
2018
Q3 		$2.58M Sell
123,687
-22,687
-15% -$537K 0.48% 64
2018
Q2 		$3.46M Sell
146,374
-20,664
-12% -$415K 0.67% 46
2018
Q1 		$2.44M Buy
+167,038
New +$2.73M 0.45% 67

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

University of Notre Dame du Lac's IMMU Position: Q1 2019 in Review

University of Notre Dame du Lac sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 124,472 shares — an estimated $1.78M sold.

University of Notre Dame du Lac first reported a position in IMMU in Q1 2018 and held it in 4 quarters. The position peaked at $3.46M in Q2 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

  • University of Notre Dame du Lac reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
  • University of Notre Dame du Lac sold 124,472 Immunomedics Inc shares in Q1 2019, an estimated $1.78M.
  • University of Notre Dame du Lac first reported a position in Immunomedics Inc in Q1 2018 and held it in 4 quarters.
  • University of Notre Dame du Lac's Immunomedics Inc position peaked at $3.46M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on University of Notre Dame du Lac's 13F filing for Q1 2019, filed 15 May 2019.